Title:
Evaluation of Serum Free Light Chains and Clonal Ig DNA in Plasma from Patients with Aggressive B-cell Lymphomas
Protocol Number:
A064
Phase:
Pilot
Physician:
Richard Ambinder
Purpose:
To estimate the amount of patients with different types of blood and tumor markers and to see if these correlate to how well a patient does in treatment.
Eligibility:
-Must be at least 18 years old - Must be HIV positive and have a diagnosis of untreated aggressive B-cell lymphoma - Must be willing to have a fine needle aspiration/biopsy if there is not enough tumor sample available
Treatment:
5 tubes of blood will be collected at time of diagnosis and/or prior to beginning treatment of the lymphoma. Samples of the tumor obtained at diagnosis will also be sampled and, if these samples are unavailable, patient will undergo a fine needle aspiration/biopsy to obtain samples. The study is concluded at this time.
Population:
Adult
Last Update
05/26/2013 04:02 AM
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts